Exascale Labs and D. Boral ARC Acquisition I Corp. have scheduled an extraordinary general meeting of BCAR shareholders for July 29, 2026, to approve their proposed business combination. Shareholders of record as of July 6, 2026, are eligible to vote at the meeting, which will be held both in person at Loeb & Loeb LLP's New York office and virtually. The business combination is expected to close shortly after shareholder approval, with the combined company operating as Exascale Labs Holdings Inc. and trading on Nasdaq under the ticker symbol XLAB. A definitive proxy statement has been filed with the SEC and mailed to shareholders, who are urged to vote promptly regardless of the number of shares held.
D. Boral ARC Acquisition I Corp. Class A Ordinary SharesShareholder vote scheduled to approve business combination with Exascale Labs, which will result in BCAR shareholders becoming owners of the combined company trading as XLAB.
Business combination with BCAR moving toward closing, enabling Exascale Labs to go public on Nasdaq under ticker XLAB.